Why Menopause Care Is Moving Online
Menopause affects every woman, yet access to knowledgeable providers has historically been limited. A 2023 survey found that only about 20% of OB-GYN residency programs provide dedicated menopause training, leaving many women without access to evidence-based care. Telehealth is helping close this gap by connecting patients with providers who specialize specifically in menopause and midlife hormonal health, regardless of geography.
Virtual menopause care is effective because the condition is managed primarily through symptom assessment, lab interpretation, and medication adjustment — all of which work well over video. Hot flashes, night sweats, mood changes, sleep disruption, vaginal dryness, and brain fog are the most common symptoms that drive women to seek help, and all can be evaluated and treated through telehealth.
Hormone Replacement Therapy Options Online
Hormone replacement therapy (HRT) remains the most effective treatment for vasomotor symptoms like hot flashes and night sweats. Telehealth menopause providers typically offer a range of HRT options including estrogen patches, pills, gels, and creams; progesterone (for women who have not had a hysterectomy); and in some cases, low-dose testosterone for libido and energy.
During your first virtual visit, the provider will review your symptoms, medical history, and risk factors to determine whether HRT is appropriate for you. They will typically order labs including a hormone panel, metabolic panel, and lipids. Many platforms use at-home lab kits for convenience. Based on results, they will prescribe a personalized HRT regimen and schedule follow-up visits at four to eight week intervals to fine-tune dosing.
Beyond HRT: Comprehensive Menopause Management
Not every woman is a candidate for HRT, and menopause management often extends beyond hormone therapy alone. Telehealth menopause platforms may also address sleep optimization, bone density monitoring, cardiovascular risk assessment, vaginal health treatments, cognitive symptoms, and mood management. Some offer non-hormonal prescription options like fezolinetant (Veozah) for hot flashes, SSRIs for mood symptoms, or gabapentin for night sweats.
The best virtual menopause care takes a whole-person approach, incorporating nutritional guidance, exercise recommendations, and stress management alongside any pharmaceutical interventions. Look for providers who treat menopause as a health transition rather than a single problem to medicate.
Perimenopause: Starting Care Early
Many women begin experiencing hormonal changes in their late 30s or early 40s, during the perimenopause transition. Symptoms can be confusing and are often misattributed to stress, thyroid problems, or mood disorders. Telehealth makes it easy to consult a menopause specialist when symptoms first emerge, rather than waiting years for a formal menopause diagnosis. Early intervention can significantly improve quality of life during the transition.
Finding the Right Menopause Provider Online
When choosing a telehealth provider for menopause, look for clinicians with specific training in menopause medicine — certifications from the North American Menopause Society (NAMS) are a strong indicator. Compare providers on their treatment philosophy (HRT-forward versus lifestyle-first), the types of hormones they prescribe (synthetic versus bioidentical), insurance acceptance, and state availability. Monthly subscription costs for menopause telehealth typically range from $75 to $250, depending on the level of support included. Browse the providers below to find a match for your needs.
Menopause Symptoms: What Telehealth Providers Treat
Menopause affects every major body system, and the symptom picture is broader than most patients expect. Telehealth menopause specialists address all of the following:
Vasomotor symptoms are the most common and most disruptive: hot flashes (sudden sensation of heat spreading across the chest, neck, and face, lasting 1 to 5 minutes), night sweats, and heat intolerance. These affect approximately 75% of women during the menopause transition and can persist for 7 to 10 years in many cases. HRT is the most effective treatment and reduces hot flash frequency by 75 to 90% in most patients.
Sleep disruption is often driven by night sweats but also involves independent changes to sleep architecture during the menopause transition. Women in perimenopause and menopause report increased difficulty falling asleep, more frequent waking, and less restorative sleep. HRT improves sleep quality in addition to reducing night sweats. Non-hormonal options include sleep hygiene protocols, CBT for insomnia, and in some cases, low-dose doxepin or trazodone.
Mood changes including irritability, anxiety, and depression are common during perimenopause. Hormonal fluctuations directly affect serotonin, norepinephrine, and GABA pathways. Estrogen has documented mood-stabilizing effects. If mood symptoms predominate, some menopause providers co-manage with an antidepressant or anti-anxiety agent alongside HRT. Platforms like Midi Health have psychiatrists and therapists in their network for this reason.
Cognitive symptoms including brain fog, difficulty concentrating, and word-finding problems are reported by 60 to 70% of women during the transition. These typically resolve after menopause stabilizes, but HRT may accelerate recovery. Current evidence does not support a long-term dementia protection effect from HRT, but the brain fog experience during the transition is real and well-documented.
Genitourinary syndrome of menopause (GSM) affects vaginal dryness, urinary urgency, recurrent UTIs, and painful intercourse. These symptoms are often underdiscussed because they are not vasomotor. Local vaginal estrogen (cream, ring, or tablet) is highly effective and carries a much lower systemic absorption profile than oral or transdermal estrogen. Telehealth providers can prescribe vaginal estrogen without an in-person exam in most states.
Bioidentical vs Synthetic vs Non-Hormonal Options
Patients frequently ask about the difference between bioidentical, synthetic, and non-hormonal options. The terminology is often used loosely and carries marketing associations that can be confusing.
FDA-approved bioidentical hormones are pharmaceutical-grade estradiol (the predominant form of estrogen used in telehealth HRT) and micronized progesterone (sold as Prometrium). These are chemically identical to the hormones produced by the human body. They are available in multiple delivery forms (patch, gel, cream, pill, vaginal ring) and are covered by most insurance plans when prescribed for menopause. This is the standard of care for most telehealth menopause platforms.
Compounded bioidentical hormones (cBHT) are custom-prepared combinations from a compounding pharmacy. These are not FDA-approved for safety and efficacy. Some compounding pharmacies prepare DHEA-estrogen-testosterone pellets or other combination formulas not available in FDA-approved form. The compounding pharmacy should be PCAB-accredited. Many telehealth platforms prefer FDA-approved options and use compounding only for specific formulations not commercially available.
Synthetic hormones include conjugated equine estrogen (Premarin) and medroxyprogesterone acetate (Provera). These were the hormones studied in the Women's Health Initiative (WHI) trial. The 2002 WHI findings -- which raised concerns about breast cancer and cardiovascular risk -- have been substantially reinterpreted since. Current guidance from the North American Menopause Society (NAMS) and the Menopause Society distinguishes between estrogen-only HRT, combined estrogen-progestogen HRT, oral versus transdermal routes, and timing relative to menopause onset.
Non-hormonal options for hot flashes include fezolinetant (Veozah, FDA-approved May 2023) -- the first non-hormonal FDA-approved treatment specifically for vasomotor symptoms. It works through a different pathway (neurokinin B receptor antagonism) and does not involve estrogen. SSRIs (especially paroxetine CR, the only FDA-approved SSRI for hot flashes), SNRIs (venlafaxine), gabapentin, and oxybutynin are also used off-label. These are appropriate for patients with hormone-sensitive cancers or strong preferences against HRT.
Insurance Coverage for Telehealth Menopause Care
Insurance coverage for telehealth menopause care has improved significantly since 2022. Here is what to know as of 2026:
Midi Health accepts insurance in more than 22 states and is in-network with major plans including Aetna, Cigna, UnitedHealthcare, and many Blue Cross Blue Shield plans. This makes Midi the most accessible insurance-covered telehealth menopause platform available nationally. For patients whose plans cover Midi, out-of-pocket costs can be as low as a standard specialist copay of $20 to $75 per visit.
Evernow accepts insurance for video visits and for most FDA-approved prescription medications. The membership fee ($29 to $49/month) is typically not covered, but the medication cost is often reimbursable.
Gennev accepts insurance in select states and works with employees at companies that have Gennev as a benefit.
Alloy Health is primarily cash-pay but HSA/FSA eligible.
Winona is cash-pay only. Prices start around $99/month and include the medication.
For patients with insurance, the practical steps are: (1) call your insurer to ask if telehealth menopause visits are covered as a specialty visit; (2) ask whether the platform you are considering is in-network; (3) confirm whether HRT prescriptions are covered under your pharmacy benefit. Most FDA-approved estradiol and progesterone formulations are on standard formularies and are inexpensive with insurance, sometimes as low as $5 to $20/month.
HSA and FSA funds can typically be used for menopause telehealth visits, HRT prescriptions, and labs -- all are considered qualified medical expenses. Most platforms issue detailed itemized receipts for HSA/FSA reimbursement.